Mediastinal hibernoma simulates a malignant lesion on dual time point FDG imaging

Lung Cancer

Volumn 59, Issue 3, 2008, Pages 391-394

  Burdick, M J ^a   Jolles, P R ^a   Grimes, M M ^a   Henry, D A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dual time point imaging; Hibernoma; Mediastinum; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANAMNESIS; ARTICLE; BACKACHE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HIBERNOMA; HISTOPATHOLOGY; HUMAN; IMAGING; MALE; MEDIASTINOSCOPY; MEDIASTINUM; MEDIASTINUM MASS; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX INJURY;

DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; LIPOMA; LIPOMATOSIS; MALE; MEDIASTINAL DISEASES; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 40249094606     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.08.020     Document Type: Article

References (26)

1. Pauwels E.K.J., Ribeiro M.J., Stoot J.H.M.B., McCready V.R., Bourquiqnon M., and Maziere B. FDG accumulation and tumor biology. Nucl Med Biol 25 (1998) 317-322
2. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomgraphy. J Thorac Imag 15 (2000) 201-204
3. Knight S.B., Delbeke D., Stewart J.R., and Sandler M.P. Evaluation of pulmonary lesions with FDG-PET. Chest 109 4 (1996) 962-968
4. 18F-fluorodeoxyglucose uptake in paranasal sinus aspergillosis: a PET study. Ann Nucl Med 12 3 (1998) 145-148
5. 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses. Br J Radiol 75 (2002) 114-121
6. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 9 (2001) 1412-1417
7. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 43 7 (2002) 871-875
8. Hustinx R., Smith R.J., Benard F., Rosenthal D.I., Machtay M., Farber L.A., et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 26 (1999) 1345-1348
9. Hamberg L.M., Hunter G.J., Alpert N.M., Choi N.C., Babich J.W., and Fischman A.J. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?. J Nucl Med 35 8 (1994) 1308-1312
10. 18FDG uptake in soft tissue masses. Eur J Nucl Med 26 (1999) 22-30
11. Chatterton B.E., Mensforth D., Coventry B.J., and Cohen P. Hibernoma: intense uptake seen on Tc-99m tetrofosmin and FDG positron emission tomographic scanning. Clin Nucl Med 27 5 (2002) 369-370
12. Lin D., Jacobs M., Percy T., Dowdy Y., and Mantil J. High 2-deoxy-2[F-18]fluoro-d-glucose uptake on positron emission tomography in hibernoma originally thought to be myxoid liposarcoma. Mol Imag Biol 7 (2005) 201-202
13. Tsuchiya T., Osanai T., Ishikawa A., Kato N., Watanabe Y., and Ogino T. Hibernomas show intense accumulation of FDG positron emission tomography. J Comput Assist Tomogr 30 (2006) 333-336
14. Ahn C., and Harvery J.C. Mediastinal hibernoma: a rare tumor. Ann Thorac Surg 50 5 (1990) 828-830
15. Udwadia Z.F., Kumar N., and Bhaduri A.S. Case report: mediastinal hibernoma. Eur J Cardiothorac Surg 15 (1999) 533-535
16. Anderson S.E., Schwab C., Stauffer E., Banic A., and Steinbach L.S. Hibernoma: imaging characteristics of a rare benign soft tissue tumor. Skeletal Radiol 30 (2001) 590-595
17. Baldi A., Santini M., Mellone P., Esposito V., Groeger A.M., Caputi M., et al. Mediastinal hibernoma: a case report. J Clin Pathol 57 (2004) 993-994
18. Furlong M.A., Fanburg-Smith J.C., and Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol 25 6 (2001) 809-814
19. Gaerte S.C., Meyer C.A., Winer-Muram H.T., Tarver R.D., and Conces D.J. Fat-containing lesions of the chest. Radiographics 22 (2002) S61-S78
20. Fan C.M., Fischman A.J., Kwek B.H., Abbara S., and Aquino S.L. Lipomatous hypertrophy of the interartrial septum: increased uptake on FDG PET. Am J Radiol 184 (2005) 339-342
21. Einarsdottir H., Soderlund V., Larsson O., Mandahl N., and Bauer H.C. 110 subfascial lipomatous tumors. MR and CT findings versus histopathological diagnosis and cytogenetic analysis. Acta Radiol 40 (1999) 603-609
22. Murphey M.D., Carroll J.F., Flemming D.J., Pope T.L., Gannon F.H., and Kransdorf M.J. From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Radiographics 24 (2004) 1433-1466
23. Hardes J., Scheil-Bertram S., Hartwig E., Gebert C., Gosheger G., and Schulte M. Sonographic findings of hibernoma. A report of two cases. J Clin Ultrasound 33 (2005) 298-301
24. Ritchie D.A., Aniq H., Davies A.M., Mangham D.C., and Helliwell T.R. Hibernoma-correlation of histopathology and magnetic-resonance-imaging features in 10 cases. Skeletal Radiol 35 (2006) 579-589
25. Kuester L.B., Fischman A.J., Fan C.M., Halpern E.F., and Aquino S.L. Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT. Chest 128 (2005) 3888-3893
26. Suzuki R., Watanabe H., Yanagawa T., Sato J., Shinozaki T., Suzuki H., et al. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Ann Nucl Med 19 (2005) 661-670